EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-05316 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr12:6178170-6179720 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOSL2MA0478.1chr12:6179494-6179505CTGAGTCATCC-6.32
HSF1MA0486.2chr12:6179454-6179467TTCCAGAATTTTC+6.14
JUNBMA0490.1chr12:6179494-6179505CTGAGTCATCC-6.14
KLF4MA0039.3chr12:6178741-6178752GCAGGGTGTGG-6.62
NFE2L1MA0089.2chr12:6178727-6178742CCTGCTGAGTCATGG-6.7
Nfe2l2MA0150.2chr12:6178729-6178744TGCTGAGTCATGGCA-6.96
ZNF263MA0528.1chr12:6179591-6179612GGAGAAGAAAGGGAAGGGAAA+6.3
ZNF263MA0528.1chr12:6179588-6179609GAAGGAGAAGAAAGGGAAGGG+6.65
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_27167chr12:6177956-6182148Esophagus
SE_37940chr12:6174260-6186334HUVEC
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr1261794296179488
chr1261786006178800
chr1261786406178845
Number: 2             
IDChromosomeStartEnd
GH12I006068chr1261780156179350
GH12I006073chr1261794586179526
Enhancer Sequence
CACCACTATG CCTGGCTAAT GTTTGTATTT TTTGTAGCCA TGGGGTTTCA CCATGTTGCC 60
CAGGCTGGTC TCCAACCCCT GGGCTCAAGC GCTCTGCCCA CTGAGCCTCC CAAAAAGCTG 120
GGATTACAGG CGTGAGCCAC CATGCCTGGC ATAAGATACA TTTCCAAGTG CTCCATGGAA 180
ACCATCTCAT TGATTGCTCC TATGAAGTGC TCATTATTAT CCCCAGTTTA CAGATGAGGA 240
AACTGAAGCA TAGAGAAGTT CAACTCATCC AAGTTCCCAA AGAAACTGAA CAGGGATCTG 300
AATACGGGCA GGTCTGTCCA GCTGCAGAGC CCAGAGCCCT TGATGCCACC TAAAACTGCC 360
TCCCGGGTTG GCTCCTACCA TTTCTCACAT GGCTGATGTC ATTCTAATCC TCCTCCAGGG 420
GCTGCAGAGA AGCTCCGGCC TGCTCCTCAC TTTACAAGCA GAGCCAAGCA TATCCCCTCC 480
AGAACCATAC CGCCTATTCT TCCCATCAGA AGCTCTATCT GCAGTCATCA CACTGGGAGC 540
ATCAGACAGC CCCACTGCCT GCTGAGTCAT GGCAGGGTGT GGAAATATGC TTGTGTGCGT 600
GGGTGCAAAT GGACCGGGAG GCGATGATCA ACAAAACTCC CAAACTAGAA AAAGATGGTC 660
AGAGCCAGGG CTTTGAGAAT GCAGAGAAGA GCGTAGTGGT TTTGTTGGCA AAATATCAAA 720
CCACTTAGTA GACAGAATTG ACACTGTTTA TCTTTTCATC AAGACATCAA GAGAATGTCT 780
TACATCCTCA GCAAAGTCAT CTTCTAGATT TTGAATTGAA GACCAGAGGA CTGTATTGTC 840
TGCCCCAGAA AACAGTCCAT CATGTACATA GTTGGTGTTC AAATAGTACT TGGATGAATG 900
GACAGTTGGA AGGATGATGG ACGGAAGATT CACCCTATAG TAAGTACTTG TTAAAACTTC 960
CTAATCTGGT GGTTACAAAC GTCTAAAAAA ACACACACAA TAAACTGAAT TCCTAATTCC 1020
ATCCACTGTG GCTCACAGAT CTCATACAAT GAGTGCTTAT TATTTAAATG TTAAAAGTGT 1080
TTTCACAGGT TAATTGCAGC AACTCATATG TCTTCCAAAG AGCTCCTTTA GTCTTGGACA 1140
TGGTGTAATT ACGTTCAGTG GAGCACAGAT ATCCCTTTCA AGAGCAATCT TTTCTCCTTC 1200
GTGCCTTCTT TAAGGGTTAC ACAAAAGATA ACCTGGCTGG GTGACCATCT CTTTGCAAGA 1260
CTAACTGATC TAGCCCACAT CTAGTTCCAG AATTTTCCCA GTGTAGAGGA CACTGGATGA 1320
GGTCCTGAGT CATCCTAAAG TCTTTAACTC ACAGACCCTA AATACAGTCC CAGGTATCCA 1380
AGCTCAACCC ACTTCAGGCC ACCAAAGGTT AGTACTGGGA AGGAGAAGAA AGGGAAGGGA 1440
AAAAGTAAGA AGTCAGGCAG TTGTGAGTTC AAGCCCTGGC TCTGCCTCGT AGCAGCTGTG 1500
TGACTTTGGG CAAGTCATTT AACCTCTCTA GGTCTGTTTC TGCTTTCCTA 1550